BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1851548)

  • 1. Structural rearrangements of the WT1 gene in Wilms' tumour cells.
    Cowell JK; Wadey RB; Haber DA; Call KM; Housman DE; Pritchard J
    Oncogene; 1991 Apr; 6(4):595-9. PubMed ID: 1851548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the WT1 gene in Wilms' tumour.
    Haber DA; Housman DE
    Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
    Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
    Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
    Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
    Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
    Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
    Wagner KJ; Roberts SG
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
    Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mosaicism in normal tissues of Wilms' tumour patients.
    Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
    Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of Wilms' tumor.
    Koo HP; Hensle TW
    Urol Clin North Am; 1993 May; 20(2):323-31. PubMed ID: 8388135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
    Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
    J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.